Article
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection.
Nature medicine - 1 Sept 2025
Campanella Gabriele, Kumar Neeraj, Nanda Swaraj, Singi Siddharth, Fluder Eugene, Kwan Ricky, Muehlstedt Silke, Pfarr Nicole, Schüffler Peter J, Häggström Ida, Neittaanmäki Noora, Akyürek Levent M, Basnet Alina, Jamaspishvili Tamara, Nasr Michel R, Croken Matthew M, Hirsch Fred R, Elkrief Arielle, Yu Helena, Ardon Orly, Goldgof Gregory M, Hameed Meera, Houldsworth Jane, Arcila Maria, Fuchs Thomas J, Vanderbilt Chad
Abstract excerpt
Artificial intelligence models using digital histopathology slides stained with hematoxylin and eosin offer promising, tissue-preserving diagnostic tools for patients with cancer. Despite their advantages, their clinical utility in real-world settings remains unproven. Assessing EGFR mutations in lung adenocarcinoma demands rapid, accurate and cost-effective tests that preserve tissue for genomic sequencing....
Read the complete abstract on PubMedTopics
- Humans
- Biomarkers, Tumor
- Lung Neoplasms
- ErbB Receptors
